Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 749 | 447 | 432 | 297 | 285 |
| Gross Profit | 749 | 447 | 432 | 297 | 285 |
| Operating Expenses | -684 | 3,381 | 1,540 | 1,208 | 1,253 |
| Operating Income | 1,433 | -2,934 | -1,108 | -911 | -968 |
| Interest Expense | 27 | 654 | 366 | 608 | 598 |
| Other Income | 14 | 13 | 2 | 1 | 1 |
| Pre-tax Income | 1,420 | -3,575 | -1,471 | -1,518 | -1,565 |
| Net Income Continuous | 1,420 | -3,575 | -1,471 | -1,518 | -1,565 |
| Net Income | $1,421 | $-3,575 | $-1,471 | $-1,518 | $-1,565 |
| EPS Basic Total Ops | 0.04 | -0.11 | -0.05 | -0.06 | -0.06 |
| EPS Basic Continuous Ops | 0.05 | -0.11 | -0.05 | -0.06 | -0.07 |
| EPS Diluted Total Ops | 0.04 | -0.11 | -0.05 | -0.06 | -0.06 |
| EPS Diluted Continuous Ops | 0.05 | -0.11 | -0.05 | -0.06 | -0.07 |
| EBITDA(a) | $1,424 | $-3,032 | $-880 | $-430 | $-963 |